304 related articles for article (PubMed ID: 31220547)
21. Activation of cannabinoid receptor type 2 attenuates surgery-induced cognitive impairment in mice through anti-inflammatory activity.
Sun L; Dong R; Xu X; Yang X; Peng M
J Neuroinflammation; 2017 Jul; 14(1):138. PubMed ID: 28724382
[TBL] [Abstract][Full Text] [Related]
22. Type-1 (CB1) cannabinoid receptor promotes neuronal differentiation and maturation of neural stem cells.
Compagnucci C; Di Siena S; Bustamante MB; Di Giacomo D; Di Tommaso M; Maccarrone M; Grimaldi P; Sette C
PLoS One; 2013; 8(1):e54271. PubMed ID: 23372698
[TBL] [Abstract][Full Text] [Related]
23. Cannabinoid type 2 receptors mediate a cell type-specific self-inhibition in cortical neurons.
Stumpf A; Parthier D; Sammons RP; Stempel AV; Breustedt J; Rost BR; Schmitz D
Neuropharmacology; 2018 Sep; 139():217-225. PubMed ID: 30025920
[TBL] [Abstract][Full Text] [Related]
24. Tingenone, a pentacyclic triterpene, induces peripheral antinociception due to cannabinoid receptors activation in mice.
Veloso CC; Ferreira RCM; Rodrigues VG; Duarte LP; Klein A; Duarte ID; Romero TRL; Perez AC
Inflammopharmacology; 2018 Feb; 26(1):227-233. PubMed ID: 28889355
[TBL] [Abstract][Full Text] [Related]
25. The endocannabinoid system: physiology and pharmacology.
Rodríguez de Fonseca F; Del Arco I; Bermudez-Silva FJ; Bilbao A; Cippitelli A; Navarro M
Alcohol Alcohol; 2005; 40(1):2-14. PubMed ID: 15550444
[TBL] [Abstract][Full Text] [Related]
26. Endocannabinoids decrease neuropathic pain-related behavior in mice through the activation of one or both peripheral CB₁ and CB₂ receptors.
Desroches J; Charron S; Bouchard JF; Beaulieu P
Neuropharmacology; 2014 Feb; 77():441-52. PubMed ID: 24148808
[TBL] [Abstract][Full Text] [Related]
27. Microinjection of 2-arachidonoyl glycerol into the rat ventral hippocampus differentially modulates contextually induced fear, depending on a persistent pain state.
Rea K; Ford GK; Olango WM; Harhen B; Roche M; Finn DP
Eur J Neurosci; 2014 Feb; 39(3):435-43. PubMed ID: 24494683
[TBL] [Abstract][Full Text] [Related]
28. Effects of Chronic Alcohol Exposure on the Modulation of Ischemia-Induced Glutamate Release via Cannabinoid Receptors in the Dorsal Hippocampus.
Zheng L; Wu X; Dong X; Ding X; Song C
Alcohol Clin Exp Res; 2015 Oct; 39(10):1908-16. PubMed ID: 26343919
[TBL] [Abstract][Full Text] [Related]
29. Cannabinoid receptor antagonists and fatty acids alter endocannabinoid system gene expression and COX activity.
Kim J; Watkins BA
J Nutr Biochem; 2014 Aug; 25(8):815-23. PubMed ID: 24854955
[TBL] [Abstract][Full Text] [Related]
30. Modern approaches to the development of synthetic cannabinoid receptor probes.
Saldaña-Shumaker SL; Grenning AJ; Cunningham CW
Pharmacol Biochem Behav; 2021 Apr; 203():173119. PubMed ID: 33508249
[TBL] [Abstract][Full Text] [Related]
31. Involvement of cannabinoid CB2 receptor in alcohol preference in mice and alcoholism in humans.
Ishiguro H; Iwasaki S; Teasenfitz L; Higuchi S; Horiuchi Y; Saito T; Arinami T; Onaivi ES
Pharmacogenomics J; 2007 Dec; 7(6):380-5. PubMed ID: 17189959
[TBL] [Abstract][Full Text] [Related]
32. CB2 cannabinoid receptor agonist selectively inhibits the mechanosensitivity of mucosal afferents in the guinea pig bladder.
Christie S; Zagorodnyuk V
Am J Physiol Renal Physiol; 2021 May; 320(5):F859-F865. PubMed ID: 33749323
[TBL] [Abstract][Full Text] [Related]
33. Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands.
Davis MP
Expert Opin Investig Drugs; 2014 Aug; 23(8):1123-40. PubMed ID: 24836296
[TBL] [Abstract][Full Text] [Related]
34. Identification and functional characterization of brainstem cannabinoid CB2 receptors.
Van Sickle MD; Duncan M; Kingsley PJ; Mouihate A; Urbani P; Mackie K; Stella N; Makriyannis A; Piomelli D; Davison JS; Marnett LJ; Di Marzo V; Pittman QJ; Patel KD; Sharkey KA
Science; 2005 Oct; 310(5746):329-32. PubMed ID: 16224028
[TBL] [Abstract][Full Text] [Related]
35. Role of the endocannabinoid system in the mechanisms involved in the LPS-induced preterm labor.
Bariani MV; Domínguez Rubio AP; Cella M; Burdet J; Franchi AM; Aisemberg J
Reproduction; 2015 Dec; 150(6):463-72. PubMed ID: 26347521
[TBL] [Abstract][Full Text] [Related]
36. Cannabinoid Receptor-2 Activation in Keratinocytes Contributes to Elevated Peripheral β-Endorphin Levels in Patients With Obstructive Jaundice.
Tao K; Zhu J; Wei K; Meng X; Zhu M; Tao Y; Lu Z; Yu W
Anesth Analg; 2021 Jul; 133(1):251-262. PubMed ID: 33560661
[TBL] [Abstract][Full Text] [Related]
37. Probable involvement of Ca(2+)-activated Cl(-) channels (CaCCs) in the activation of CB1 cannabinoid receptors.
Romero TR; Pacheco Dda F; Duarte ID
Life Sci; 2013 May; 92(14-16):815-20. PubMed ID: 23123446
[TBL] [Abstract][Full Text] [Related]
38. Cannabinoid-2 receptor activation protects against infarct and ischemia-reperfusion heart injury.
Wang PF; Jiang LS; Bu J; Huang XJ; Song W; Du YP; He B
J Cardiovasc Pharmacol; 2012 Apr; 59(4):301-7. PubMed ID: 22113346
[TBL] [Abstract][Full Text] [Related]
39. Role of cannabinoid CB2 receptor in the reinforcing actions of ethanol.
Ortega-Álvaro A; Ternianov A; Aracil-Fernández A; Navarrete F; García-Gutiérrez MS; Manzanares J
Addict Biol; 2015 Jan; 20(1):43-55. PubMed ID: 23855434
[TBL] [Abstract][Full Text] [Related]
40. Cannabinoid 2 receptor is a novel anti-inflammatory target in experimental proliferative vitreoretinopathy.
Szczesniak AM; Porter RF; Toguri JT; Borowska-Fielding J; Gebremeskel S; Siwakoti A; Johnston B; Lehmann C; Kelly ME
Neuropharmacology; 2017 Feb; 113(Pt B):627-638. PubMed ID: 27569993
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
